Does ABCL pay a dividend?

No significant news for in the past two years. ABCL is not currently paying a regular dividend. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements.

What are abcellera Biologics' stock price targets?

10 equities research analysts have issued 12 month price objectives for AbCellera Biologics' stock. Their ABCL share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $21.88 in the next year. This suggests a possible upside of 399.4% from the stock's current price.

How did abcellera biologics (ABCL) perform in the quarter?

AbCellera Biologics Inc. (NASDAQ:ABCL) posted its quarterly earnings results on Thursday, August, 3rd. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.02. The firm had revenue of $10.10 million for the quarter, compared to analyst estimates of $12.38 million.